Artelo Biosciences, Inc.
ARTL
$1.91
$0.2615.76%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 41.83% | 28.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.94% | 32.41% | |||
| Operating Income | 1.94% | -32.41% | |||
| Income Before Tax | 3.14% | -35.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.14% | -35.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.14% | -35.79% | |||
| EBIT | 1.94% | -32.41% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 29.35% | -10.88% | |||
| Normalized Basic EPS | 29.35% | -10.89% | |||
| EPS Diluted | 29.35% | -10.88% | |||
| Normalized Diluted EPS | 29.35% | -10.89% | |||
| Average Basic Shares Outstanding | 37.11% | -85.00% | |||
| Average Diluted Shares Outstanding | 37.11% | -85.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||